EU Clinical Trial Information System (CTIS)

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

The purpose of this study is to confirm the dose of roflumilast to be used for asthma management by comparing the effects of 250 mcg and 500 mcg oral roflumilast with placebo on pulmonary function and asthma symptoms.

The FLASH Study: A study of roflumilast versus placebo in patients with asthma (BY217/M2-023)

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

ALTANA Pharma

ALTANA Pharma

ALTANA Pharma

ALTANA Pharma

ALTANA Pharma

ALTANA Pharma

ALTANA Pharma

ALTANA Pharma

Documents available

BY217-M2-023-RDS-2007-01-23.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator